05:46 AM EDT, 08/07/2026 (MT Newswires) -- Swedish pharmaceutical company Klaria (KLAR.ST) received a notice of allowance from the European Patent Office for a new patent on Sumatriptan Alginate Film, SAF. The notice indicates that the patent, the second in the company's SAF patent portfolio, and all its claims will be granted entirely, according to a Friday release. The second patent for the pharmaceutical product will broaden the protections by granting patents in major markets including the European Union.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.